← FDA DRUG APPROVALS

FDA ANDA · ANDA090334

BACLOFEN

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA090334
TYPE
ANDA
ORIGINAL APPROVAL
2010-02-18
LATEST ACTION
2023-05-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued, Prescription

Products

BACLOFENDiscontinued
BACLOFEN 20MG · TABLET · ORAL
BACLOFENPrescription
BACLOFEN 5MG · TABLET · ORAL
BACLOFENDiscontinued
BACLOFEN 10MG · TABLET · ORAL

Approval history

2023-05-23Labeling · Supplement 3 · standardAP
2010-02-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →